Eton Pharmaceuticals, Inc. ETON EBITDA margin

EBITDA margin at other companies

HRO

HarrowHROW

-0.3%-7.5pp

XER

Xeris Biopharma Holdings, Inc.XERS

11.3%+8.9pp

ANI PharmaceuticalsANIP

24.1%+12.9pp

Zevra Therapeutics, Inc.ZVRA

65.5%+37.8pp

Ultragenyx PharmaceuticalRARE

-69%-6.4pp

Rigel PharmaceuticalsRIGL

42.4%+19.5pp

FAQ

What is Eton Pharmaceuticals, Inc.'s EBITDA margin?

Eton Pharmaceuticals, Inc. (ETON) reported EBITDA margin of -0.6% in Q3 2025.

How has Eton Pharmaceuticals, Inc.'s EBITDA margin changed year-over-year?

Eton Pharmaceuticals, Inc.'s EBITDA margin increased by 94.7% year-over-year, from -11.8% to -0.6%.

What is the long-term trend for Eton Pharmaceuticals, Inc.'s EBITDA margin?

Over 2 years (2020 to 2024), Eton Pharmaceuticals, Inc.'s EBITDA margin has grown at a -99.0% compound annual growth rate (CAGR), from -67,846.2% to -6.6%.

What does EBITDA margin mean?

EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.